Literature DB >> 8061590

Helicobacter pylori: the link with gastric cancer.

E De Koster1, M Buset, E Fernandes, M Deltenre.   

Abstract

Gastric cancer is the world's overall second most common cancer, and carries a bad prognosis. In the Correa model of gastric carcinogenesis, environmental factors (salt, nitrate, a lack of vitamin C and beta-carotene, bile reflux, bacterial overgrowth in atrophic gastritis with nitrosamine formation) are related to the evolution from normal gastric tissue through superficial gastritis, multifocal atrophic gastritis, intestinal metaplasia and dysplasia to carcinoma. The incidence of H. pylori decreases with progressing preneoplastic lesions. In several studies, the prevalence of H. pylori was elevated in patients with gastric cancer, with a trend for a higher prevalence in intestinal type gastric cancer vs diffuse type. Family members of patients with gastric adenocarcinoma have a higher H. pylori prevalence than controls; patients infected with H. pylori have more family members with gastric cancer. Several epidemiological studies showed a higher H. pylori prevalence in regions or populations with high gastric cancer risk vs low-risk populations. Large-scale studies in China and Europe showed a correlation between H. pylori seroprevalence and gastric cancer incidence and mortality. Three prospective nested case-control studies showed that infection with H. pylori increased the risk of further development of gastric adenocarcinoma, showing that H. pylori infection precedes the development of gastric cancer. Several pathways can be identified explaining the association between H. pylori and gastric adenocarcinoma. We showed that gastric cell proliferation is increased in parallel with inflammation. The ascorbic acid concentrating mechanism is abolished in gastritis. Ammonia, generated by H. pylori's urease, gives rise to gastric mucosal atrophy. We showed that salt increases the gastric cell proliferation only in H. pylori-infected individuals. The organism's toxin may play a role in gastric cancer. Besides H. pylori, other environmental factors are important in determining the gastric cancer risk. For instance, we showed that in Belgium, Maghreb immigrants have a high prevalence of H. pylori infection but a low prevalence of intestinal metaplasia and gastric cancer. Gastric lymphoma is rare (about 5% of all gastric tumours), but its incidence is steadily increasing. It was shown that H. pylori also increases the risk for low-grade as well as high-grade gastric lymphoma. Eradication of H. pylori has been shown to cure several cases of unequivocally proven gastric low-grade lymphoma.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8061590     DOI: 10.1097/00008469-199403030-00003

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

1.  Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication.

Authors:  P Willis; D A Lynch; R Prescott; S Lamonby
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 2.  Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Authors:  Z Xu; J Li; H Wang; G Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-27       Impact factor: 3.267

3.  Studies on N-nitroso bile acid amides in relation to their possible role in gastrointestinal cancer.

Authors:  B Dayal; N H Ertel
Journal:  Lipids       Date:  1997-12       Impact factor: 1.880

4.  H pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade.

Authors:  Yong-Chang Chen; Ying Wang; Jing-Yan Li; Wen-Rong Xu; You-Li Zhang
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 5.  Helicobacter pylori γ-glutamyl transpeptidase: a formidable virulence factor.

Authors:  Samantha Shi Min Ling; Khay Guan Yeoh; Bow Ho
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

6.  Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer.

Authors:  Shegan Gao; Shuoguo Li; Zhikun Ma; Shuo Liang; Tanyou Shan; Mengxi Zhang; Xiaojuan Zhu; Pengfei Zhang; Gang Liu; Fuyou Zhou; Xiang Yuan; Ruinuo Jia; Jan Potempa; David A Scott; Richard J Lamont; Huizhi Wang; Xiaoshan Feng
Journal:  Infect Agent Cancer       Date:  2016-01-19       Impact factor: 2.965

Review 7.  Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review.

Authors:  Peter L Miller; Tiffany L Carson
Journal:  Gut Pathog       Date:  2020-09-10       Impact factor: 4.181

Review 8.  Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma.

Authors:  Daniel Rolf; Gabriele Reinartz; Stephan Rehn; Christopher Kittel; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

9.  Association of oral microbiome and pancreatic cancer: a systematic review and meta-analysis.

Authors:  Mengyao Yuan; Ying Xu; Zhimin Guo
Journal:  Therap Adv Gastroenterol       Date:  2022-09-22       Impact factor: 4.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.